National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$35.50
add to cart

Rights & Permissions

topleft topright

The Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa: Global and Local Challenges and Solutions: Workshop Summary (2011)
Board on Health Sciences Policy (HSP)

Citation Manager

. "Appendix A: Agenda." The Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa: Global and Local Challenges and Solutions: Workshop Summary. Washington, DC: The National Academies Press, 2011.

Please select a format:

BibTeX EndNote RefMan


Page
96
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


The Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa: Global and Local Challenges and Solutions - Summary of a Joint Workshop by the Institute of Medicine and the Academy of Science of South Africa

IOM is partnering with the Academy of Science of South Africa (ASSAf) to convene a 2-day workshop on MDR TB. The workshop will bring together disease experts, community leaders, policy makers, and patient advocates to examine the state of MDR TB in the South Africa region, to learn from the experiences of the South African public health community in its fight against MDR TB, and to draw lessons regarding best practices and novel approaches that can be applied both within and beyond the region. Proceedings of the workshop will be published and disseminated globally.

The South Africa meeting will focus on various aspects of MDR TB:

  1. Epidemiology. The latest information on the spread of MDR/XDR TB in Africa and globally, including the nature of the coinfection with HIV, will be presented and discussed.

  2. Diagnostics and Preventive Therapies. The challenges associated with rapid diagnosis of TB and resistance testing in resource-constrained environments will be explored, as well as opportunities for expansion of laboratory capacity and point-of-care diagnosis.

  3. Treatment. The limitations of current treatment, including the capacity of current health systems to address the needs of TB patients, the limited numbers of patients receiving appropriate treatment, and challenges in treating migrant workers, will be examined.

  4. Transmission and Infection Control. The meeting will explore our growing understanding of the modes of transmission of MDR TB, and the strategies needed to address them.

  5. Pediatric TB. The devastating spread of MDR TB among children and the unique challenges they pose for prevention and treatment will be explored.

  6. Policy. The workshop will analyze the effects of MDR TB beyond patients in order to highlight areas for improved policy and next steps.

Page
96